| mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
0.0046 |
0.9 |
| mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
0.0074 |
0.9 |
| mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
0.0036 |
0.9 |
| mRNA |
EX-527 |
GDSC1000 |
pan-cancer |
AAC |
-0.0038 |
0.9 |